Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Liveritas Biosciences Inc. has 1 pending office action in the Semiconductors, Circuits & Optics technology area. This matter is being handled by a distinct examiner in 1 distinct art unit. The current prosecution footprint is singular, with all activity consolidated under this specific examiner and art unit, requiring a focused approach to this specific examination.
WILLIAMS, JAMEL E is the busiest examiner for the company, overseeing the busiest examiner pending office action. This pending matter represents the entirety of the company's current active pipeline at the USPTO. The concentration of the portfolio under a single examiner allows for a direct and consistent dialogue during the prosecution of the semiconductor technology.
Practitioners should note that the alignment of the pending matter within the specified technology area ensures that the examination is conducted by a specialist in circuits and optics. The focus on a single examiner and art unit provides a streamlined prosecution environment. This structure minimizes the complexity often associated with managing multiple examiner relationships across different technical units at the USPTO.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIAMS, JAMEL E | 1 | 88.8% | +9.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628626 | INTEGRATED PLATFORM FOR MASS SPECTROMETRY | WILLIAMS, JAMEL E | — |
| Art Unit | Apps |
|---|---|
| 2855 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18628626 | INTEGRATED PLATFORM FOR MASS SPECTROMETRY | WILLIAMS, JAMEL E | 2855 | §102§103 | Non-Final OA | — | Pending | Apr 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLiveritas Biosciences Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jamel E Williams has the most, with 1 of Liveritas Biosciences Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.